Possible indication for surgical treatment of squamous cell carcinomas of the esophagus that involve the stomach

Surgery

Volumn 133, Issue 5, 2003, Pages 479-485

  Doki, Yuichiro ^a   Ishikawa, Osamu ^a   Kabuto, Toshiyuki ^a   Hiratsuka, Masahiro ^a   Sasaki, Yo ^a   Ohigashi, Hiroaki ^a   Kameyama, Masao ^a   Murata, Kohei ^a   Yamada, Terumasa ^a   Miyashiro, Isao ^a   Yokoyama, Shigekazu ^a   Imaoka, Shingi ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIAPHRAGM; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; GASTRECTOMY; HUMAN; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PANCREAS RESECTION; PARAAORTIC LYMPH NODE; PERICARDIUM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 0038441645     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.134     Document Type: Article

References (24)

1. Roth JA, Putnam JB, Rich TA, Forastiere AA. Cancer: principles and practice of oncology, 5th ed. Philadelphia: J.B. Lippincott Company; 1997.
2. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett=s metaplasia. Lancet 2000;356:2079-85.
3. The Japanese Society for Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan (1995-1997), 2nd ed. Tokyo: Japanese Society for Esophageal Diseases; 2001.
4. Kabuto T, Yasuda T, Furukawa H, Higashiyama M, Takami K, Yokouchi H, et al. Combined resection of the aorta for an esophageal carcinoma invading the aorta through a right transthoracic approach. Jpn J Thorac Cardiovasc Surg 1999;47:611-6.
5. Matsubara T, Ueda M, Kokudo N, Takahashi T, Muto T, Yanagisawa A. Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 2001;25:279-84.
6. Ichiyoshi Y, Kawahara H, Taga S, Yoshino I, Ohsaki T, Kohno H, et al. Indications and operative techniques for combined aortoesophageal resection. Jpn J Thorac Cardiovasc Surg 1999;47:318-24.
7. Watanabe Y, Kashihara S, Kiyonari N, Tsuji Y, Hisano K, Okada M. Combined resection of the thoracic esophagus and thoracic descending aorta. Jpn J Thorac Cardiovasc Surg 1999;47:495-8.
8. Altorki NK, Migliore M, Skinner DB. Esophageal carcinoma with airway invasion. Evolution and choices of therapy. Chest 1994;106:742-5.
9. Kuwano H, Baba K, Ikebe M, Kitamura K, Adachi Y, Mori M, et al. Gastric involvement of oesophageal squamous cell carcinoma. Br J Surg 1992;79:328-30.
10. Maeta M, Koga S, Shimizu N, Hamazoe R, Inoue Y. Clinicopathologic study of esophageal cancer associated with simultaneous metastatic lesions in the stomach. J Surg Oncol 1988;38:143-6.
11. Saito T, Iizuka T, Kato H, Watanabe H. Esophageal carcinoma metastatic to the stomach. A clinicopathologic study of 35 cases. Cancer 1985;56:2235-41.
12. Doki Y, Kabuto T, Ishikawa O, Ohigashi H, Sasaki Y, Yamada T, et al. Does pleural lavage cytology before thoracic closure predict both padent=s prognosis and site of cancer recurrence after resection of esophageal cancer? Surgery 2001;130:792-7.
13. Doki Y, Ishikawa O, Mano M, Hiratsuka M, Sasaki Y, Kameyama M, et al. Cytokeratin deposit in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers. J Surg Res 2002;107:75-81.
14. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-73.
15. Yasuda T, Kabuto T, Ishiguro S, Nakano H, Nakamori S, Ohigashi H, et al: Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus. Gan To Kagaku Ryoho 1995;22:1538-41.
16. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and/or MJ lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999;17:2915-21.
17. Ishida K, Iizuka T, Ando N, Ide H. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial. Jpn J Clin Oncol 1996;26:310-5.
18. Sharma D, Krasnow SH, Davis EB, Lunzer S, Hussain MA, Wadleigh RG. Sequential chemotherapy and radiotherapy for squamous cell esophageal carcinoma. Am J Clin Oncol 1997;20:151-3.
19. Yano M, Tsujinaka T, Shiozaki H, Inoue M, Doki Y, Yamamoto M, et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol 1999;70:25-32.
20. Matsubara T, Ueda M, Takahashi T, Nakajima T, Nishi M. Localization of recurrent disease after extended lymph node dissection for carcinoma of the thoracic esophagus. J Am Coll Surg 1996;182:340-6.
21. Dresner SM, Griffin SM. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 2000;87:1426-33.
22. Bhansali MS, Fujita H, Kakegawa T, Yamaha H, Ono T, Hikita S, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997;21:275-81.
23. Komori T, Doki Y, Kabuto T, Ishikawa O, Hiratsuka M, Sasaki Y, et al. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers. J Surg Oncol 2003;82:19-27.
24. Shimada Y. Imamura M, Sato F, Maeda M, Kaganoi J, Hashimoto Y, et al. Indications for abdominal para-aortic lymph node dissection in patients with esophageal squamous cell carcinoma. Surgery 2002;132:93-9.